Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Down – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) gapped down prior to trading on Friday . The stock had previously closed at $8.38, but opened at $7.83. Coloplast A/S shares last traded at $7.92, with a volume of 21,573 shares.

Analyst Ratings Changes

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold”.

Coloplast A/S Price Performance

The stock’s fifty day moving average price is $8.67 and its 200-day moving average price is $9.09. The firm has a market cap of $17.52 billion, a PE ratio of 32.40, a price-to-earnings-growth ratio of 0.83 and a beta of 0.26. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.61 and a quick ratio of 1.00.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The firm had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.12 billion. Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. As a group, equities analysts expect that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.